On November 30, 2023, the Supreme Court of Illinois ruled in favor of limiting the scope of Biometric Information Privacy Act (BIPA) as it relates to the collection of biometric information from healthcare workers if said biometric information is collected and used for purposes of healthcare treatment, payments, or operations under HIPAA.
The ruling comes after a lawsuit, Mosby v. The Ingalls Memorial Hospital, was filed against the Ingalls Memorial Hospital by Lucille Mosby, a nurse employed there, both individually and on behalf of others in a similar situation. The hospital utilized medication dispensing systems which required employees to authenticate via finger-scan in order to have access to the medication administered to patients. The issue at hand here was that the technology for the finger scanning belonged to a third party and that biometric data was collected without expressly written consent, and that it appeared as if the biometric data of healthcare staff did not benefit from the same level of protection as that of regular individuals.
In light of these allegations, there two questions that the Court had to answer:
“Whether the exclusion in Section 10 of [the Biometric Information Privacy Act (Act) (740 ILCS 14/10 (West 2018))] for ‘information collected, used, or stored for healthcare treatment, payment, or operations under the federal Health [I]nsurance [P]ortability and Accountability Act of 1996’ [(HIPAA)] applies to biometric information of healthcare workers (as opposed to patients) collected, used or stored for healthcare treatment, payment or operations under HIPAA,”
and
“Does finger-scan information collected by a healthcare provider from its employees fall within the [Act’s] exclusion for ‘information collected, used, or stored for healthcare treatment, payment, or operations under [HIPAA],’ 740 ILCS 14/10 [(West 2018)], when the employee’s finger-scan information is used for purposes related to ‘healthcare,’ ‘treatment,’ ‘payment,’ or ‘operations’ as those terms are defined by the HIPAA statute and regulations?”
Section 10 of BIPA offers definitions to be considered in the Act and even starts with the definition for ‘biometric identifier,’ which it defines as follows:
"Biometric identifier" means a retina or iris scan, fingerprint, voiceprint, or scan of hand or face geometry. Biometric identifiers do not include writing samples, written signatures, photographs, human biological samples used for valid scientific testing or screening, demographic data, tattoo descriptions, or physical descriptions such as height, weight, hair color, or eye color. Biometric identifiers do not include donated organs, tissues, or parts as defined in the Illinois Anatomical Gift Act or blood or serum stored on behalf of recipients or potential recipients of living or cadaveric transplants and obtained or stored by a federally designated organ procurement agency. Biometric identifiers do not include biological materials regulated under the Genetic Information Privacy Act.
The part cited in the lawsuit states as follows:
Biometric identifiers do not include information captured from a patient in a healthcare setting or information collected, used, or stored for healthcare treatment, payment, or operations under the federal Health Insurance Portability and Accountability Act of 1996.
The discussions revolved around the way the statute of the Act was phrased, particularly around the use of the words “information” and “or,” or the way treatment, payment, and operations were defined under HIPAA. The Court’s argument was as follows:
In answering in the affirmative to both questions mentioned above, the Court however clarified that it was not “construing the language at issue as a broad, categorical exclusion of biometric identifiers taken from healthcare workers. Here, the nurses’ biometric information, as alleged in the complaints, was collected, used, and stored to access medications and medical supplies for patient healthcare treatment and is excluded from coverage under the Act because it is “information collected, used, or stored for healthcare treatment, payment, or operations under [HIPAA].”
Now that the Mosby decision has been issued by the Supreme Court, it remains to be seen how this will be extended by lower Courts, if at all. Also, this might lead to the dismissal of other pending BIPA lawsuits against healthcare entities where similar technology for medication management is used.